(AMRZ) Amrize - Overview
Sector: Basic Materials | Industry: Building Materials | Exchange: NYSE (USA) | Market Cap: 27.478m USD | Total Return: -4.8% in 12m
Avg Turnover: 139M
Qual. Beats: 0
Rev. Trend: 94.4%
Warnings
Altman Z'' 1.05 < 1.0 - financial distress zone
Choppy
Tailwinds
No distinct edge detected
Amrize AG (AMRZ), headquartered in Switzerland, specializes in building materials and envelope solutions for the North American infrastructure, commercial, and residential sectors. The company operates through two primary divisions: Building Materials, which focuses on heavy commodities like cement and asphalt, and Building Envelope, which provides specialized roofing, wall systems, and waterproofing technologies.
The business model relies on vertical integration within the construction supply chain, combining high-volume raw materials with higher-margin technical components such as synthetic membranes and sealants. In the construction materials sector, profitability is often dictated by regional logistics and proximity to infrastructure projects due to the high cost of transporting heavy aggregates.
Investors can evaluate the companys valuation metrics and growth potential on ValueRay.
The firm underwent a significant rebranding from Holcim North America Finance Ltd in 2013 and was formally incorporated in its current structure in 2023. This transition reflects a strategic focus on the North American market, where infrastructure spending remains a primary driver for cement and ready-mix concrete demand.
- Federal infrastructure spending levels dictate demand for bulk cement and aggregates
- Residential housing starts drive sales for roofing and building envelope systems
- Fluctuating energy costs impact manufacturing margins for asphalt and concrete production
- Regulatory shifts in carbon emission standards increase capital expenditure for cement plants
| Net Income: 1.16b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.63 > 1.0 |
| NWC/Revenue: 10.33% < 20% (prev 11.08%; Δ -0.75% < -1%) |
| CFO/TA 0.09 > 3% & CFO 2.17b > Net Income 1.16b |
| Net Debt (6.62b) to EBITDA (2.79b): 2.38 < 3 |
| Current Ratio: 1.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (553.2m) vs 12m ago 0.09% < -2% |
| Gross Margin: 25.38% > 18% (prev 0.26%; Δ 2.51k% > 0.5%) |
| Asset Turnover: 51.15% > 50% (prev 52.09%; Δ -0.94% > 0%) |
| Interest Coverage Ratio: 5.08 > 6 (EBITDA TTM 2.79b / Interest Expense TTM 365.0m) |
| A: 0.05 (Total Current Assets 4.28b - Total Current Liabilities 3.05b) / Total Assets 24.3b |
| B: 0.03 (Retained Earnings 785.0m / Total Assets 24.3b) |
| C: 0.08 (EBIT TTM 1.85b / Avg Total Assets 23.3b) |
| D: 0.07 (Book Value of Equity 785.0m / Total Liabilities 11.2b) |
| Altman-Z'' = 1.05 = BB |
| DSRI: 0.95 (Receivables 1.36b/1.40b, Revenue 11.9b/11.6b) |
| GMI: 1.02 (GM 25.38% / 25.99%) |
| AQI: 0.93 (AQ_t 0.45 / AQ_t-1 0.49) |
| SGI: 1.03 (Revenue 11.9b / 11.6b) |
| TATA: -0.04 (NI 1.16b - CFO 2.17b) / TA 24.3b) |
| Beneish M = -3.11 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 49.95 with a total of 2,112,116 shares traded.
Over the past week, the price has changed by +1.92%,
over one month by -13.02%,
over three months by -23.40% and
over the past year by -4.82%.
Amrize has no consensus analysts rating.
P/E Trailing = 23.7512
P/E Forward = 18.4502
P/S = 2.3067
P/B = 2.2359
P/EG = 1.4233
Revenue TTM = 11.9b USD
EBIT TTM = 1.85b USD
EBITDA TTM = 2.79b USD
Long Term Debt = 4.94b USD (from longTermDebt, last quarter)
Short Term Debt = 1.24b USD (from shortTermDebt, last quarter)
Debt = 7.72b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.05b
Net Debt = 6.62b USD (calculated: Debt 7.72b - CCE 1.10b)
Enterprise Value = 34.1b USD (27.5b + Debt 7.72b - CCE 1.10b)
Interest Coverage Ratio = 5.08 (Ebit TTM 1.85b / Interest Expense TTM 365.0m)
EV/FCF = 25.85x (Enterprise Value 34.1b / FCF TTM 1.32b)
FCF Yield = 3.87% (FCF TTM 1.32b / Enterprise Value 34.1b)
FCF Margin = 11.07% (FCF TTM 1.32b / Revenue TTM 11.9b)
Net Margin = 9.70% (Net Income TTM 1.16b / Revenue TTM 11.9b)
Gross Margin = 25.38% ((Revenue TTM 11.9b - Cost of Revenue TTM 8.89b) / Revenue TTM)
Gross Margin QoQ = 9.69% (prev 26.77%)
Tobins Q-Ratio = 1.41 (Enterprise Value 34.1b / Total Assets 24.3b)
Interest Expense / Debt = 4.73% (Interest Expense 365.0m / Debt 7.72b)
Taxrate = 21.62% (326.0m / 1.51b)
NOPAT = 1.45b (EBIT 1.85b * (1 - 21.62%))
Current Ratio = 1.40 (Total Current Assets 4.28b / Total Current Liabilities 3.05b)
Debt / Equity = 0.59 (Debt 7.72b / totalStockholderEquity, last quarter 13.1b)
Debt / EBITDA = 2.38 (Net Debt 6.62b / EBITDA 2.79b)
Debt / FCF = 5.02 (Net Debt 6.62b / FCF TTM 1.32b)
Total Stockholder Equity = 12.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.96% (Net Income 1.16b / Total Assets 24.3b)
RoE = 8.95% (Net Income TTM 1.16b / Total Stockholder Equity 12.9b)
RoCE = 10.38% (EBIT 1.85b / Capital Employed (Equity 12.9b + L.T.Debt 4.94b))
RoIC = 6.51% (NOPAT 1.45b / Invested Capital 22.3b)
WACC = 8.60% (E(27.5b)/V(35.2b) * Re(9.98%) + D(7.72b)/V(35.2b) * Rd(4.73%) * (1-Tc(0.22)))
Discount Rate = 9.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 58.04 | Cagr: 0.04%
[DCF] Terminal Value 74.21% ; FCFF base≈1.33b ; Y1≈1.31b ; Y5≈1.33b
[DCF] Fair Price = 24.08 (EV 20.0b - Net Debt 6.62b = Equity 13.3b / Shares 553.5m; r=8.60% [WACC]; 5y FCF grow -2.44% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.29 | # QB: 0
Revenue Correlation: 94.38 | Revenue CAGR: 0.59% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.01 | Chg30d=+6.29% | Revisions=+20% | Analysts=7
EPS next Quarter (2026-09-30): EPS=1.17 | Chg30d=-0.61% | Revisions=-20% | Analysts=7
EPS current Year (2026-12-31): EPS=2.69 | Chg30d=-0.20% | Revisions=-29% | GrowthEPS=+25.8% | GrowthRev=+5.2%
EPS next Year (2027-12-31): EPS=3.13 | Chg30d=-0.03% | Revisions=-20% | GrowthEPS=+16.2% | GrowthRev=+5.7%
[Analyst] Revisions Ratio: -29%